Business Wire

Commission Must Change Course on Reusable Packaging Demands – EPPA

17.11.2022 07:00:00 EET | Business Wire | Press release

Share

As the EU prepares to set strict new targets on packaging waste, a mounting body of evidence shows that proposed targets on reusables are unscientific, unsustainable and unnecessary.

The European Paper Packaging Alliance (EPPA) has issued fresh calls for the European Commission to put the full product life cycle at the heart of its vision for a circular economy, and not to use the upcoming Packaging and Packaging Waste Regulation proposal to effectively outlaw packaging solutions that are more sustainable.

The latest evidence comes from a new life cycle analysis study, which shows that recyclable, paper-based packaging used in the food delivery and takeaway sector offers significant environmental advantages over reusable systems across 12 ‘impact categories’ including climate change, freshwater consumption and resource depletion.

The results show that switching to reusable alternatives would generate 48% more CO2-equivalent emissions, consume 39% more freshwater and demand 82% more mineral and resource extraction.

Analysis of the results shows that this is because transporting food and beverage containers back to restaurants after use, together with washing and drying them hygienically, consumes far more energy, water and resources.

This LCA study adds to a range of other evidence which shows that reusable container systems are not the panacea which some seem to believe.

Commenting on the findings, Eric Le Lay, President of the European Paper Packaging Alliance said:

This is more proof that reusable packaging is not always the best solution for the environment. It is imperative that proper life cycle analysis be reflected in the text of the EU’s Packaging and Packaging Waste Regulation proposal.

The leaked draft text of the regulation is disappointing. It sets unrealistic and discriminatory reuse targets for in-store dining and takeaway services. The European Commission should embrace the scientific evidence that single-use, paper-based containers are not only far more practical for food delivery services and their customers, improving hygiene and convenience, but simply perform better on key environmental metrics.”

Antonio D’Amato, Vice President of EPPA, also commented:

Protecting the planet is too important a priority to be left to ideology. The planet's health demands a rigorous scientific approach and substantial investment in new technology and innovation, which can only be generated by sustainable growth.

Europe and indeed the entire world face energy and water scarcity and food shortages, yet the Commission's current proposals would escalate carbon emissions and resource depletion, accelerate water stress and increase food waste. We should instead be working together on solutions that are truly sustainable for the environment, the economy and employment. We are convinced that the circular economy, in which we have all invested billions of euros over 30 years’ hard work and innovation, is the only way to provide sustainable solutions for the environment, economy and employment.

The study was commissioned by EPPA. The full study including its methodology description is available for download here.

About EPPA
The European Paper Packaging Alliance is a non-for-profit food and foodservice packaging association. The priorities of the Alliance are to find concrete solutions to increase recycling and to reduce carbon emissions of food and foodservice packaging without compromising food safety and human health protection. More information is available here.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Roxana Moldovan
+32 485955210

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye